Investment considerations
Be part
Be part
of revolution
We are convinced that Aesyra solution has a very large potential because it addresses an unmet medical need, it can positively impact the quality of life of the patients and potentially prevent other sleep disorders. We are delighted of our fund’s second investment in Aesyra that fits perfectly into VitaTech’s strategy to invest in companies positioned at the convergence of Healthcare and Technology.
Paolo Orsatti
Director VitaTech
Market
AesyBite™ perfectly fits in this existing market as it addresses the main pains (ability to monitor and relieve the condition) without modifying the customer behavior (bite for bruxism prescribed by dentists to their patients).
*Compound Annual Growth Rate
Achievements so far
Be an investor
The AesyBite platform is ready to integrate many sensor technologies and address needs in different markets.
Do you want to know more about our product pipeline?
